Scarica l'app Stockscreener
5.12
4.70%
0.23
Dopo l'orario di chiusura:
5.10
-0.02
-0.39%
Clene Inc Borsa (CLNN) Ultime notizie
Top Nanotechnology Stocks To Follow NowApril 5th - marketbeat.com
Best Nanotechnology Stocks To Keep An Eye OnApril 4th - MarketBeat
Clene (NASDAQ:CLNN) Major Shareholder Sells $21,261.66 in Stock - MarketBeat
Clene Inc. ten percent owner sells $21k in stock By Investing.com - Investing.com Australia
Clene Inc. ten percent owner sells $21k in stock - investing.com
Clene (CLNN) 10% holder’s LLC sells 4,278 shares, keeps 426,816 - Stock Titan
Promising Nanotechnology Stocks To ResearchApril 1st - MarketBeat
Clene Inc. (CLNN) ten percent owner sells $494k in stock - Investing.com Canada
Symbiosis II sells multiple CLNN shares (NASDAQ: CLNN) in early 2026 - Stock Titan
Entity linked to Clene (CLNN) sells 100,997 common shares - Stock Titan
Sentiment Review: Is Clene Inc a play on infrastructure spending2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 29th - marketbeat.com
EPS Watch: What hedge funds are buying Clene Inc Equity WarrantMarket Volume Summary & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Top Nanotechnology Stocks To Keep An Eye OnMarch 28th - marketbeat.com
Market Outlook: Should I buy Clene Inc Equity Warrant stock now2026 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Nanotechnology Stocks To ResearchMarch 27th - marketbeat.com
Clene Inc. ten percent owner sells $99k in shares By Investing.com - Investing.com India
Aug Catalysts: Is Clene Inc a top pick in the sectorTrade Risk Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Clene Inc. ten percent owner sells $99k in shares - Investing.com
Clene (CLNN) holder SymBiosis II sells 17,909 common shares - Stock Titan
Nanotechnology Stocks Worth WatchingMarch 26th - MarketBeat
Top Nanotechnology Stocks To Add to Your WatchlistMarch 25th - MarketBeat
Risk Analysis: Can Clene Inc reach resistance levels soon2026 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Aug Big Picture: Will Clene Inc benefit from AI trendsGlobal Markets & Growth Focused Entry Reports - baoquankhu1.vn
Symbiosis II LLC plans resale of CLNN (NASDAQ: CLNN) — 477,000 shares - Stock Titan
CLNN Stock Price, Quote & Chart | CLENE INC (NASDAQ:CLNN) - ChartMill
Nanotechnology Stocks To ConsiderMarch 22nd - MarketBeat
If You Invested $1,000 in Clene (CLNN) - Stock Titan
Top Nanotechnology Stocks To ConsiderMarch 21st - MarketBeat
Whale Trades: Will Clene Inc Equity Warrant outperform during market rallies2026 Key Lessons & Fast Momentum Entry Tips - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Hengan International Group Co (OtherHEGIF) and Clene (CLNN) - The Globe and Mail
Highs Report: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAR - baoquankhu1.vn
Clene Secures Third-Year NIH Subaward for ALS Program - The Globe and Mail
Treasury Yields: Is Clene Inc Equity Warrant stock undervalued right nowPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayMarch 17th - MarketBeat
Clene Inc. Announces NIH Subaward Agreement for ALS Expanded Access Protocol – SEC Filing Details - Minichart
Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook - Minichart
Clene 10-K: Revenue $0.2M, EPS $(2.65) — Net Loss $(26.17)M - TradingView
Clene (NASDAQ: CLNN) pushes CNM-Au8 toward accelerated ALS approval - Stock Titan
Clene Inc. (NASDAQ: CLNN) secures $8M Year 3 ALS grant funding - Stock Titan
Clene (CLNN) Projected to Post Earnings on Monday - marketbeat.com
Q1 Earnings Estimate for Clene Issued By HC Wainwright - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 15th - MarketBeat
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and American Public Education (APEI) - The Globe and Mail
Clene Inc. (NASDAQ:CLNN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
Clene (NASDAQ:CLNN) Receives Buy Rating from Canaccord Genuity Group - MarketBeat
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):